Citizens Financial Group Inc. RI Buys 1,342 Shares of Becton, Dickinson and Company (NYSE:BDX)

Key Points

• Citizens Financial Group Inc. RI increased its stake in Becton, Dickinson and Company by 82.7% in Q1, owning a total of 2,964 shares now valued at $679,000.
• Becton, Dickinson reported $3.68 EPS in its last earnings announcement, surpassing analysts' expectations of $3.40 and showing a 10.4% year-over-year revenue growth.
• The company declared a quarterly dividend of $1.04, resulting in an annualized dividend of $4.16 with a 2.1% dividend yield.

Citizens Financial Group Inc. RI grew its position in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 82.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,964 shares of the medical instruments supplier's stock after purchasing an additional 1,342 shares during the quarter. Citizens Financial Group Inc. RI's holdings in Becton, Dickinson and Company were worth $679,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of BDX. Northcape Wealth Management LLC lifted its holdings in shares of Becton, Dickinson and Company by 0.5% during the first quarter. Northcape Wealth Management LLC now owns 9,814 shares of the medical instruments supplier's stock worth $2,248,000 after buying an additional 51 shares during the last quarter. Alpha Omega Wealth Management LLC grew its stake in shares of Becton, Dickinson and Company by 5.7% in the first quarter. Alpha Omega Wealth Management LLC now owns 984 shares of the medical instruments supplier's stock worth $225,000 after acquiring an additional 53 shares during the last quarter. Brady Family Wealth LLC increased its position in Becton, Dickinson and Company by 1.2% during the first quarter. Brady Family Wealth LLC now owns 4,317 shares of the medical instruments supplier's stock worth $989,000 after acquiring an additional 53 shares during the period. Diversified Trust Co raised its stake in Becton, Dickinson and Company by 4.7% during the 1st quarter. Diversified Trust Co now owns 1,188 shares of the medical instruments supplier's stock valued at $272,000 after purchasing an additional 53 shares during the last quarter. Finally, REAP Financial Group LLC boosted its holdings in Becton, Dickinson and Company by 75.3% in the 4th quarter. REAP Financial Group LLC now owns 128 shares of the medical instruments supplier's stock valued at $29,000 after purchasing an additional 55 shares during the period. Institutional investors own 86.97% of the company's stock.

Becton, Dickinson and Company Stock Performance

Becton, Dickinson and Company stock opened at $193.65 on Friday. The firm has a market capitalization of $55.50 billion, a P/E ratio of 34.83, a P/E/G ratio of 1.42 and a beta of 0.20. The stock has a fifty day moving average price of $175.81 and a two-hundred day moving average price of $198.98. Becton, Dickinson and Company has a 52-week low of $163.33 and a 52-week high of $251.99. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.10 and a quick ratio of 0.64.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $3.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.40 by $0.28. Becton, Dickinson and Company had a net margin of 7.51% and a return on equity of 16.23%. The business had revenue of $5.51 billion during the quarter, compared to analysts' expectations of $5.50 billion. During the same quarter last year, the company posted $3.50 EPS. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. As a group, analysts anticipate that Becton, Dickinson and Company will post 14.43 EPS for the current fiscal year.

Becton, Dickinson and Company Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 8th will be issued a $1.04 dividend. This represents a $4.16 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Monday, September 8th. Becton, Dickinson and Company's payout ratio is presently 79.39%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on BDX. The Goldman Sachs Group downgraded shares of Becton, Dickinson and Company from a "buy" rating to a "neutral" rating and set a $192.00 price objective on the stock. in a report on Friday, May 2nd. Barclays lowered their price target on Becton, Dickinson and Company from $261.00 to $241.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 3rd. Piper Sandler upped their price target on Becton, Dickinson and Company from $185.00 to $200.00 and gave the company a "neutral" rating in a report on Friday. Raymond James Financial lowered Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a report on Friday, May 2nd. Finally, Morgan Stanley cut their target price on Becton, Dickinson and Company from $280.00 to $196.00 and set an "overweight" rating for the company in a research note on Tuesday, May 6th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Becton, Dickinson and Company currently has a consensus rating of "Hold" and an average target price of $211.33.

Insider Transactions at Becton, Dickinson and Company

In related news, EVP David Shan sold 1,166 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $171.19, for a total transaction of $199,607.54. Following the sale, the executive vice president directly owned 4,575 shares in the company, valued at $783,194.25. This represents a 20.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael David Garrison sold 1,185 shares of Becton, Dickinson and Company stock in a transaction on Friday, July 18th. The shares were sold at an average price of $180.29, for a total value of $213,643.65. Following the completion of the transaction, the executive vice president owned 4,887 shares of the company's stock, valued at approximately $881,077.23. The trade was a 19.52% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 3,214 shares of company stock valued at $579,206 in the last three months. 0.36% of the stock is owned by corporate insiders.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.